{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,26]],"date-time":"2026-03-26T23:57:25Z","timestamp":1774569445330,"version":"3.50.1"},"reference-count":16,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2006,9,1]],"date-time":"2006-09-01T00:00:00Z","timestamp":1157068800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["International Journal of Antimicrobial Agents"],"published-print":{"date-parts":[[2006,9]]},"DOI":"10.1016\/j.ijantimicag.2006.04.006","type":"journal-article","created":{"date-parts":[[2006,8,22]],"date-time":"2006-08-22T12:03:03Z","timestamp":1156248183000},"page":"262-265","source":"Crossref","is-referenced-by-count":45,"title":["Voriconazole brain tissue levels in rhinocerebral aspergillosis in a successfully treated young woman"],"prefix":"10.1016","volume":"28","author":[{"given":"Thomas","family":"Elter","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michal","family":"Sieniawski","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Axel","family":"Gossmann","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Claudia","family":"Wickenhauser","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ursula","family":"Schr\u00f6der","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Harald","family":"Seifert","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Johannes","family":"Kuchta","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J\u00fcrgen","family":"Burhenne","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Klaus-Dieter","family":"Riedel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gerd","family":"F\u00e4tkenheuer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Oliver A.","family":"Cornely","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ijantimicag.2006.04.006_bib1","doi-asserted-by":"crossref","first-page":"2348","DOI":"10.1128\/AAC.47.7.2348-2350.2003","article-title":"Development and validation of a high performance liquid chromatography assay for voriconazole","volume":"47","author":"Pennick","year":"2003","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.ijantimicag.2006.04.006_bib2","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1002\/ana.410180511","article-title":"Aspergillosis of the central nervous system: clinicopathological analysis of 17 patients","volume":"18","author":"Walsh","year":"1985","journal-title":"Ann Neurol"},{"key":"10.1016\/j.ijantimicag.2006.04.006_bib3","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1111\/jon199443123","article-title":"Central nervous system aspergillosis. Analysis of 26 patients","volume":"4","author":"Boes","year":"1994","journal-title":"J Neuroimaging"},{"key":"10.1016\/j.ijantimicag.2006.04.006_bib4","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1007\/BF01967060","article-title":"Fungal infections in cancer patients: an international autopsy survey","volume":"11","author":"Bodey","year":"1992","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"10.1016\/j.ijantimicag.2006.04.006_bib5","doi-asserted-by":"crossref","first-page":"1147","DOI":"10.1093\/clinids\/12.6.1147","article-title":"Antifungal and surgical treatment of invasive aspergillosis: review of 2,121 published cases","volume":"12","author":"Denning","year":"1990","journal-title":"Rev Infect Dis"},{"key":"10.1016\/j.ijantimicag.2006.04.006_bib6","doi-asserted-by":"crossref","first-page":"608","DOI":"10.1093\/clinids\/23.3.608","article-title":"Therapeutic outcome in invasive aspergillosis","volume":"23","author":"Denning","year":"1996","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.ijantimicag.2006.04.006_bib7","doi-asserted-by":"crossref","first-page":"696","DOI":"10.1086\/313756","article-title":"Practice guidelines for diseases caused by Aspergillus","volume":"30","author":"Stevens","year":"2000","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.ijantimicag.2006.04.006_bib8","series-title":"Recent trends in the discovery, development and evaluation of antifungal agents.","first-page":"223","article-title":"The pharmacokinetics of itraconazole in animals and man: an overview","author":"Heykants","year":"1987"},{"key":"10.1016\/j.ijantimicag.2006.04.006_bib9","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1128\/AAC.33.3.362","article-title":"Tissue concentrations and bioactivity of amphotericin B in cancer patients treated with amphotericin B-deoxycholate","volume":"33","author":"Collette","year":"1989","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.ijantimicag.2006.04.006_bib10","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1097\/00005792-200007000-00006","article-title":"Invasive aspergillosis. Disease spectrum, treatment practices, and outcomes. I3 Aspergillus Study Group","volume":"79","author":"Patterson","year":"2000","journal-title":"Medicine (Baltimore)"},{"key":"10.1016\/j.ijantimicag.2006.04.006_bib11","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1093\/jac\/27.4.535","article-title":"Tissue distribution and bioactivity of amphotericin B administered in liposomes to cancer patients","volume":"27","author":"Collette","year":"1991","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.ijantimicag.2006.04.006_bib12","doi-asserted-by":"crossref","first-page":"2339","DOI":"10.1128\/AAC.41.11.2339","article-title":"Preliminary animal pharmacokinetics of the parenteral antifungal agent MK-0991 (L-743,872)","volume":"41","author":"Hajdu","year":"1997","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.ijantimicag.2006.04.006_bib13","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1517\/13543784.11.3.409","article-title":"Review of the safety and efficacy of voriconazole","volume":"11","author":"Hoffman","year":"2002","journal-title":"Expert Opin Investig Drugs"},{"key":"10.1016\/j.ijantimicag.2006.04.006_bib14","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1056\/NEJMoa020191","article-title":"Voriconazole versus amphotericin B for primary therapy of invasive aspergillosis","volume":"347","author":"Herbrecht","year":"2002","journal-title":"N Engl Med J"},{"key":"10.1016\/j.ijantimicag.2006.04.006_bib15","doi-asserted-by":"crossref","first-page":"2641","DOI":"10.1182\/blood-2005-02-0733","article-title":"Improved outcome in central nervous system aspergillosis, using voriconazole treatment","volume":"106","author":"Schwartz","year":"2005","journal-title":"Blood"},{"key":"10.1016\/j.ijantimicag.2006.04.006_bib16","doi-asserted-by":"crossref","first-page":"728","DOI":"10.1086\/377131","article-title":"Voriconazole concentrations in the cerebrospinal fluid and brain tissue of guinea pigs and immunocompromised patients","volume":"37","author":"Lutsar","year":"2003","journal-title":"Clin Infect Dis"}],"container-title":["International Journal of Antimicrobial Agents"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S092485790600207X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S092485790600207X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,4,20]],"date-time":"2019-04-20T19:35:35Z","timestamp":1555788935000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S092485790600207X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,9]]},"references-count":16,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2006,9]]}},"alternative-id":["S092485790600207X"],"URL":"https:\/\/doi.org\/10.1016\/j.ijantimicag.2006.04.006","relation":{},"ISSN":["0924-8579"],"issn-type":[{"value":"0924-8579","type":"print"}],"subject":[],"published":{"date-parts":[[2006,9]]}}}